SCHEMBL19686009

SCHEMBL19686009

Cc1coc2cc(N3c4ccccc4C(c4ccccc4)(c4ccccc4)c4ccccc43)ccc2c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.37
KDM4E B2RXH2 8/20 0.37
HPGD P15428 4/20 0.37
HSD17B10 Q99714 3/20 0.37
USP2 O75604 2/20 0.37
MAOB P27338 2/20 0.36
NPC1 O15118 6/20 0.34
RAB9A P51151 6/20 0.34
SMN1; SMN2 Q16637 6/20 0.34
MAPT P10636 5/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
TP53 P04637 2/20 0.34
CYP3A4 P08684 2/20 0.34
POLB P06746 3/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PTPN2 P17706 1/20 0.33
PTPN1 P18031 1/20 0.33
GAA P10253 3/20 0.32
MAPK1 P28482 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19685675 0.91 ALDH1A1 (0.35) ALDH1A1KDM4EHSD17B10MAOBRAB9A
SCHEMBL19686011 0.89 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDHSD17B10USP2
SCHEMBL19685674 0.87 KDM4E (0.36) ALDH1A1KDM4EHPGDHSD17B10USP2
SCHEMBL19685678 0.86 KDM4E (0.35) ALDH1A1KDM4EHPGDHSD17B10USP2
SCHEMBL17752238 0.83 PTGER4 (0.41) ALDH1A1KDM4EHPGDHSD17B10NPC1
SCHEMBL19686102 0.83 ITGB2 (0.31) ALDH1A1HSD17B10USP2MEN1KMT2A
SCHEMBL19685902 0.83 ALDH1A1 (0.32) ALDH1A1HPGDHSD17B10USP2SMN1; SMN2
SCHEMBL19685947 0.81 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDHSD17B10USP2
SCHEMBL17752241 0.80 PTGER4 (0.46) ALDH1A1KDM4EHPGDHSD17B10NPC1
SCHEMBL19686256 0.80 KMT2A (0.35) ALDH1A1KDM4EHPGDHSD17B10USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-14 US disclosed
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same CYC1, CCNA1, CYCS ALDH1A1 572/4885KDM4E 1138/4885HPGD 901/4885
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS ALDH1A1 572/4885KDM4E 1138/4885HPGD 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.